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ABSTRACT: A phytochemical study of a Serjania marginata
leaf extract with antiulcer activity afforded 15 compounds,
including the new 3-O-α-L-arabinopyranosyl(1→3)-α-L-
rhamnopyranosyl(1→2)[β-D-glucopyranosyl(1→4)]-α-L-
arabinopyranosyloleanolic acid (1) and 7,5″-anhydroapigenin 8-
C-α-(2,6-dideoxy-5-hydroxy-ribo-hexopyranosyl)-4′-O-β-D-glu-
copyranoside (4). The structures of the new compounds were
determined by spectroscopic analysis, including 1D and 2D
NMR techniques, mass spectrometry, and chemical methods.
Compound 4 is a C-hexopyranosylapigenin with an unusual
cyclic ether linkage between C-5″ and C-7 of apigenin. The
isolated proanthocyanidins have high antioxidant activities, and these compounds are probably responsible for the
gastroprotective effect of the extract.
The Sapindaceae family is widely distributed in Brazil,where there are two major biogeographic formations,
namely, Cerrado and Pantanal.1 Sapindaceae species have been
investigated in relation to their therapeutic properties based on
traditional knowledge. Plants are a rich source of saponins,2
flavonoids, proanthocyanidins, isoprenoids, polyphenols, triter-
penoids, diterpenoids, lecithin, and hydrogels.3,4 The Serjania
genus belongs to the Sapindaceae family, and it occurs in
tropical and subtropical regions, with 226 species that are
mostly lianas.5 Crude extracts of these plants showed diverse
biological activities, including anti-inflammatory,6 antioxidant,
antibacterial,4 and antiulcer7 in Serjania erecta; antiprotozoal,8
larvicidal,9 antibacterial,3 and anti-inflammatory10 in S. lethalis;
molluscicidal and antifungal11 in S. triquetra; antioxidant12 in S.
glabrata; trypanocidal13 in S. yucatanensis; and antiulcer and
antispasmodic14 in S. caracasana.
Only a few studies have been carried out on the chemical
constituents of the Serjania genus. Epicatechin, kaempferol,
kaempferol-3-O-α-L-rhamnopyranoside, kaempferol-3-O-α-L-
rhamnopyranosyl(1→6)-β-D-glucopyranoside, kaempferol-3,7-
di-O-α-L-rhamnopyranoside, vitexin, and isovitexin were
isolated from S. erecta extracts.4 The saponins serjanosides A,
B, and C, with oleanolic acid as the sapogenin, were isolated
from the methanol extract of S. lethalis.15 Hydrolysis of the
methanol extract of the aerial parts of S. triquetra afforded the
sapogenins 11α-hydroperoxyhederagenin, stigmasterol, olea-
nolic acid, hederagenin, and morolic acid.16 The saponins
salzmannianosides A and B, pulsatilla saponin D, and
hederacolchiside A1 were isolated from the methanol extract
of S. salzmanniana stems.11
A wide range of pharmacological activities have been
described for Serjania extracts, but only a few phytochemical
studies on these species have been reported. The juice from the
leaves of S. marginata, which is native to Paraguay, Bolivia,
Argentina, and Brazil, where it is known as “cipo-́uva” and
“cipo-́timbo”́, is employed in folk medicine for internal use
against stomach pains. A 70% ethanol extract of S. marginata
leaves was studied to assess the antiulcerogenic activity in
models of acute gastric ulcer in rodents (ethanol and
indomethacin), and the results confirmed that the S. marginata
extract possesses antiulcer activity.17
A wide plant biodiversity, in addition to social contrasts,
makes the use of medicinal plants a common practice in Brazil,
where it is estimated that 82% of the population use products
based on medicinal plants. However, only 8% of the species
have been studied in research on bioactive compounds.18 The
Biota/FAPESP research program for the sustainable use of
Brazilian biodiversity (www.biota.org.br) includes the search for
potential medicinal plants for future use in the Brazilian Public
Health System (SUS). Preliminary studies on the antiulcero-
genic effects of S. marginata extracts were promising, and it is
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important to ascertain the chemical composition of these
extracts. Herein a chemical analysis of the ethanolic extract of S.
marginata leaves, as well as a correlation between isolated
compounds and antioxidant activity, is reported.
■ RESULTS AND DISCUSSION
The 70% ethanolic extract from the leaves of S. marginata
yielded 15 pure compounds: 3-O-D-β-glucopyranosylsitoster-
ol,19 the saponins pulsatilla saponin D,20 hederacolchiside A1,
21
salzmannianoside B,11 and compound 1, the flavonoids
quercetin 3-O-α-L-rhamnopyranoside,22 epicatechin,23 cassiaoc-
cidentalin A (2),24 tetrastigma B (3),25 apigenin 6-C-β-
boivinopyranosyl-7-O-β-D-glucopyranoside,26 apigenin 6-C-[2-
O-α-L-rhamnopyranosyl(1→2)]-β-D-xylopyranoside,27 and
compound 4, and the proanthocyanidins proanthocyanidins
A-1 and A-228 and cinnamtannin B-1 (Figure 1).29 The
absolute configurations of the sugar moieties were verified by
measurement of the optical rotation of each purified sugar after
acid hydrolysis of fractions A and B. The configurations were D
for the glucose and L for the rhamnose and arabinose sugars.
Compound 1 was isolated as the major component from the
saponin fraction, and this compound gave a quasi-molecular ion
peak at m/z 1027.5475 [M − H]− (calcd 1027.5478) in the
HRESIMS, which, in conjunction with the 13C NMR data, is
consistent with the molecular formula C52H84O20. The NMR
features of compound 1 (Table 1) had similar characteristics to
those of previously described saponins from the genus
Serjania.11 Analysis of the 13C NMR chemical shifts of the
shielded signals suggests that oleanolic acid is the aglycone.
This assertion was confirmed by the 1H−1H COSY, TOCSY,
ROESY, HSQC, and HMBC data.
Concerning the carbohydrate portion of compound 1, the 1H
NMR spectrum contained signals for four anomeric protons at
δ 6.26, 5.30, 5.12, and 4.74 (Table 1). These protons showed
correlations in the HSQC spectrum with carbon signals at δ
101.4, 107.4, 106.6, and 105.0, respectively. Individual sugar
units were identified by 1D-TOCSY and 1D-ROESY experi-
ments involving selective excitation of each anomeric proton.30
Selective 1D-TOCSY experiments on the signal at δ 5.12
showed a typical spin system of a β-glucopyranosyl moiety. The
NOE associations observed in the 1D-ROESY experiment
between the anomeric proton and H-3 and H-5 were consistent
with the structure of this sugar. The results of 1D-TOCSY
experiments on the anomeric signals at δ 6.26 (brs) and 1.55
(d, 6.1 Hz) were consistent with a rhamnopyranosyl unit.31 The
selective excitation of the methyl group indicated axial−axial
relationships between H-5/H-4 and H-4/H-3. The absence of
correlations between the anomeric proton and H-3 and H-5 in
the 1D-ROESY spectrum confirmed the identification as an α-
rhamnopyranosyl moiety. Likewise, anomeric signals at δ 5.30
and 4.74 showed TOCSY patterns reminiscent of the spin
system of two arabinopyranosyl units (Figure 2), in which the
coupling constants are consistent with trans-diaxial H-1/H-2
and H-2/H-3 arrangements. The J3,4 = 3.6 Hz magnitude of H-
4Ara′ (δ 4.17 dd) indicated the equatorial position of H-4. This
arrangement was supported by the 1D-ROESY spectra of both
anomeric signals, which showed correlations with H-3 and H-
5ax. Finally, an HSQC experiment unambiguously showed the
complete correlations of the proton and carbon signals of the
tetrasaccharide portion.
The connection between each of the sugar units and the
aglycone was elucidated by HMBC/ROESY correlations
between anomeric protons and the corresponding carbon/
proton signals of the positions in which the sugars were O-
bonded. Long-range HMBC/ROESY correlations were ob-
served between H-1Ara′ (δ 5.30) and C-3Rha (δ 82.9)/H-3Rha (δ
4.72), H-1Rha (δ 6.26) and C-2Ara (δ 75.8)/H-2Ara (δ 4.51), H-
1Glc (δ 5.12) and C-4Ara (δ 80.1)/H-4Ara (δ 4.21), H-1Ara (δ
4.74), and C-3 (δ 88.7)/H-3 (δ 3.25) of oleanolic acid. These
observations provided evidence of the same glycosidic chain as
reported for salzmannianoside B,11 which was isolated from S.
salzmanniana and gave similar NMR data for this portion of the
molecule (Table 2). The configurations were D for the glucose
and L for the rhamnose and arabinose sugars based on the
hydrolysis of the saponins fraction (A).
The structure of compound 1 was therefore 3-O-α-L-
arabinopyranosyl(1→3)-α-L-rhamnopyranosyl(1→2)[β-D-
glucopyranosyl(1→4)]-α-L-arabinopyranosyloleanolic acid
(Figure 1). A literature review showed that 1 was reported
earlier as raddeanoside R23 by Fan and co-workers from the
rhizome of Anemone raddeana.32 Comparison of the reported
NMR data was consistent with most of the signals observed for
compound 1, but those of the terminal arabinopyranoside
differed significantly (Table 2). The NMR data assigned to its
anomeric position were quite different. However, comparison
of the chemical shifts observed for an isomer of compound 1
described by Hai et al.33 from Clematis argentilucida, which has
a ribopyranosyl instead of a terminal arabinopyranosyl moiety,
indicated that the compound isolated by Fan et al. from
Anemone raddeana contained a ribose unit (Table 2), and,
consequently, the reported structure should be revised. It is
Figure 1. Structures of serjanioside D (1), cassiaoccidentalin A (2),
tetrastigma B (3), and serjanione A (4).
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interesting to note that both plants belong to the same family,
Ranunculaceae, rather than the Serjania genus (Sapindaceae).
T h u s , 3 -O -α - L - a r a b i n o p y r a n o s y l ( 1→ 3 ) -α - L -
rhamnopyranosyl(1→2)[β-D-glucopyranosyl(1→4)]-α-L-
arabinopyranosyloleanolic acid is a new compound, and we
propose to name it serjanoside D.
Only the flavonoid C-glucosides, vitexin, and isovitexin have
been described previously for the Serjania genus.4 In the work
described here, cassiaoccidentalin A (2), tetrastigma B (3),
apigenin 6-C-β-boivinopyranosyl-7-O-β-glucopyranoside, apige-
nin 6-C-[2-O-α-L-rhamnopyranosyl(1→2)]-β-D-xylopyranoside,
and compound 4 were isolated. The NMR signals of C-
glycosidic flavonoids are generally doubled or broadened, an
observation that is generally attributed to the presence of
rotamers in solution.34,35 In addition, for cassiaoccidentalin A
(2) and tetrastigma B (3) (Figure 1), a change of the
multiplicity of the H-1″ and H-2″ resonances of 6-deoxy-ribo-
hex-3-ulopyranose sugar was observed when the compounds
were dissolved in the protic solvent MeOH-d4. The doublets at
δ 5.21 (10.0 Hz) and 5.04 (10.0 Hz) observed in fresh MeOH-
d4 solution in the
1H NMR spectrum of tetrastigma B (3)
changed over time. The anomeric proton signal was converted
to a singlet and the H-2″ signal disappeared (Figure 3). The
2D-ROESY spectrum showed a correlation between H-1″ and
H-5″, indicating that epimerization had not occurred at C-1″.
Liu and co-workers36,37 reported that oxoglycosides showed
enolization of the carbonyl group in solution. In the cases of
cassiaoccidentalin A (2) and tetrastigma B (3), enolization
(Figure 3) would explain the fast deuteration at C-2″ and,
consequently, the disappearance of the signal in the 1H NMR
spectrum and the simplification of the H-1″ signal to a singlet.
This behavior has not been described previously for C-
oxoglycosidic flavones and should be taken into consideration
for NMR metabolomics studies, which are usually carried out in
protic solvents.
Minor compound 4 has the molecular formula C27H28O13
determined from its HRESIMS, and the 1H and 13C NMR
spectra showed characteristic signals of a C-glycosylated
Table 1. 1H NMR (600 MHz) and 13C NMR (125 MHz) Spectroscopic Data for Serjanoside D (1) in Pyridine-d5
position δC, type δH (J in Hz) position δC, type δH (J in Hz)
1 38.9, CH2 ax 0.91;
a eq 1.45a Ara
2 26.7, CH2 ax 1.80;
a eq 2.06a 1 105.1, CH 4.74, d (6.6)
3 88.7, CH 3.25, dd (11.8, 4.3) 2 75.8, CH 4.51, dd (6.6, 7.8)
4 39.5, C 3 74.7, CH 4.19a
5 56.0, CH 0.79, brd (12.0) 4 80.1, CH 4.21, brs
6 18.5, CH2 1.49;
a 1.27a 5 65.2, CH2 ax 4.38;
a eq 3.74, brd (10.6)
7 33.2, CH2 1.46;
a 1.26a
8 39.7, C Rha
9 48.0, CH 1.64, t (8.8) 1 101.4, CH 6.26, brs
10 37.0, C 2 71.8, CH 4.92, brs
11 23.6, CH2 1.89, dd (8.8, 3.2) 3 82.9, CH 4.72, dd (9.6, 3.2)
12 122.5, CH 5.46, t (3.2) 4 73.0, CH 4.45, ddd (9.6, 9.5, 2.5)
13 144.8, C 5 69.5, CH 4.67, dq (9.5, 6.1)
14 42.1, C 6 18.5, CH3 1.55, d (6.1)
15 28.3, CH2 ax 2.16, brdd (13.1, 13.1); eq 1.17
a
16 23.6, CH2 ax 2.10, brdd (13.1, 12.1); eq 1.95, brd (12.1) Glc
17 46.6, C 1 106.7, CH 5.12, d (7.9)
18 42.0, CH 3.29, dd (13.8, 3.9) 2 75.5, CH 4.02, dd (7.9, 9.0)
19 46.4, CH2 ax 1.79, dd (13.8, 13.8); eq 1.27
a 3 78.5, CH 4.17, dd (9.0, 9.0)
20 30.9, C 4 71.2, CH 4.24, dd (9.0, 9.4)
21 34.2, CH2 ax 1.43;
a eq 1.17a 5 78.8, CH 3.89, ddd (9.4; 4.9; 2.4)
22 33.2, CH2 ax 2.03;
a eq 1.80a 6 62.5, CH2 4.50, brd (12,2); 4.38, dd (12.2; 4.9)
23 28.2, CH3 1.32, s
24 17.2, CH3 1.15, s Ara′
25 15.5, CH3 0.83, s 1 107.4, CH 5.30, d (7.2)
26 17.4, CH3 0.99, s 2 73.2, CH 4.53, dd (7.2, 8.6)
27 26.2, CH3 1.29, s 3 74.6, CH 4.17, dd (8.6, 3.6)
28 180.1, C 4 69.5, CH 4.28, brs
29 33.2, CH3 0.94, s 5 67.1, CH2 ax 4.32, dd (12.2, 2.7); eq 3.81
30 23.7, CH3 0.99, s brd (12.2)
aOverlapped signals.
Figure 2. 1D TOCSY (bottom, mix = 0.15 s) and 1D ROESY (top,
mix = 0.2 s) spectra obtained from the anomeric proton (5.30 ppm) of
the arabinose moiety. The arrows indicate the ROE correlations
between axial protons.
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apigenin as in the flavones described previously. Furthermore,
in the 1H NMR spectrum signals were observed that are
consistent with two anomeric protons, δ 5.39 dd (5.0, 1.5 Hz)
and 5.04 d (7.4 Hz), which correlate with carbon signals at δ
64.5 and 101.7 in the HSQC spectrum. These observations
indicate the presence of C- and O-glycosidic units, respectively.
The MS/MS spectrum of the molecular ion showed the
fragment ion peak at m/z 399 (M + H − 162), corresponding
to the loss of an O-hexosyl unit (Figure 4). The chemical shift
of the corresponding signals38 and the correlation observed in
the 2D-TOCSY spectrum between the anomeric proton signal
and each of the hexosyl signals, including H-6,30 indicates the
presence of one glucose unit. The coupling constant for H-1 is
characteristic of a β-configuration.
The doublet at δ 7.27 (2H, J = 9 Hz) corresponding to the
protons H-3′/5′ of the B ring was deshielded, and this is
consistent with glycosylation of the C-4′ hydroxy group. The
C-4′ connection of the glucopyranosyl moiety was confirmed
by the ROESY correlation observed between H-1glc (δ 5.04)
and H-3′/5′ (δ 7.27).
In addition to the glucosyl signals, the 1H NMR spectrum
contained an anomeric signal at δ 5.39 (1H, dd, J = 5.0; 1.5 Hz)
that was correlated with δ 64.5 (C-1″). Analysis of the 2D
TOCSY and 1H−1H COSY spectra allowed the spin system for
this sugar to be identified as [−O−CHR−CH2−CHOH−
CHOH−], and the following assignments were made: H-1″ (δ
5.39, dd, J = 5.0; 1.5 Hz); H-2″ (δ 2.48, ddd, 14.7, 5.0, 3.6 Hz
and δ 2.30, ddd, 14.7, 1.5, 2.2 Hz); H-3″ (δ 4.14, m); and H-4″
(δ 3.66, d, 4.5 Hz), with correlations with the 13C NMR signals
C-1″ (δ 64.5); C-2″ (δ 37.4); C-3″ (δ 67.0); and C-4″ (δ 73.6),
which are consistent with a 2-deoxysugar. A three-proton
singlet at δ 1.63 was correlated with C-4″ (δ 73.6) and the
quaternary carbon, δ 102.4, in the HMBC (Figure 4), which
suggests a 6″-deoxy unit and a fully substituted C-5″. The
pyranoside form of the sugar was determined by the correlation
observed in the HMBC experiment between the anomeric
proton signal (δ 5.39) and C-5″ (δ 102.4). The chemical shift
for C-5″ was consistent with its dioxygenated substitution. A
natural hexopyranoside monosaccharide with C-5″ dioxygena-
tion could not be traced in the literature. Synthetic sugars with
a 5″-hydroxy group have been described,39 and the chemical
shifts of the signals for C-5″ and C-6″ in the 1H and 13C NMR
spectra are consistent with those of compound 4.
The coupling constants of the anomeric proton signal at δ
5.39 dd (5.0, 1.5 Hz) indicate that there is no axial−axial
arrangement with one of the H-2″ protons, and we, therefore,
consider that H-1″ is α. The 2D-ROESY spectrum shows a
correlation between one of the C-2″ protons (δ 2.48, ddd, 14.7,
5.0, 3.6 Hz) and H-4″ (δ 3.66, d, 4.5 Hz), thus indicating that
both are in axial positions. On the other hand, the observed
coupling constants for H-2ax″, H-3″, and H-4″ are consistent
with an equatorial arrangement of H-3″. The relative
configurations deduced for H-2″, H-3″, and H-4″ are consistent
with those found in the literature.38,40 All of these values
indicate the relative configuration of the sugar as shown in
Figure 4, which corresponds to a α-2,6-dideoxy-5-hydroxy-ribo-
hexopyranosyl moiety.
The chemical shift (δ 64.5) observed in the 13C NMR
spectrum for C-1″ is typical of a C-glycosidic bond. The C-8
position for the glycosylation is proposed on the basis of the
correlation in the 1D ROE spectrum (Figure 4) between H-1″
(δ 5.39, dd, 5.0, 1.7 Hz) and H-2′/6′ (δ 7.93, d, 9.0 Hz).
The molecular formula C27H28O13 is consistent with an
additional unsaturation that would arise from a cyclic ether.
The HMBC spectrum showed a weak correlation of C-6″ (δ
1.63) with C-7 (δ 159.9), and this is consistent with a cyclic
ether between C-7 and C-5″. O,C-Fused glycosidic flavonoids
are rare but have been described in the literature.41 The
minimized structure42 showed theoretical values for coupling
constants that are consistent with the experimental values
(Figure 4).
Table 2. Chemical Shifts of the Terminal Sugar for Serjanoside D (1) and Those Reported for Salzmannianoside B,11
Raddeanoside R23,
32 and 3β-O-{β-D-Ribopyranosyl(1→3)-α-L-rhamnopyranosyl(1→2)-[β-D-glucopyranosyl(1→4)]-β-D-
xylopyranosyl}oleanolic Acid33 (Ribopyranosyl Derivative) in Pyridine-d5
compound 1a salzmannianoside Bb raddeanoside R23
a ribopyranosyl derivativeb
position δC δH (J in Hz) δC δH (J in Hz) δC δH (J in Hz) δC δH (J in Hz)
1 107.4 5.30, d (7.2) 106.8 5.31, d (7.2) 104.8 5.99, d (3.6) 104.7 5.96, d (4.2)
2 73.2 4.53, dd (7.2, 8.6) 72.6 4.54, m 72.8 4.48−4.52, m 72.9 4.32, m
3 74.6 4.17, dd (8.6, 3.6) 74.0 4.11, m 70.4 4.35−4.37, m 68.8 4.50, m
4 69.5 4.28, brs 69.0 4.17−4.25, m 68.7 4.31−4.35, m 70.4 4.17, m
5 67.1 ax 4.32, dd (12.2, 2.7); eq 3.81, brd (12.2) 65.4 4.34−4.38, m; 3.58, d (12.2) 65.3 4.14−4.18, m 65.3 4.35, m; 4.17, m
a600 MHz. b500 MHz.
Figure 3. 1H NMR spectra of fresh solution (bottom) and solution
after 12 h (top) of tetrastigma B (3) in MeOH-d4. The modifications
of H-1″ and H-2″ signals can be attributed to the deuteration of C-2″
through the enolization shown. The arrows indicate the ROE
correlations between protons H-1″ and H-5″.
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Thus, compound 4 was identified as apigenin 7,5″-anhydro-
8-C-α-(2,6-dideoxy-5-hydroxy-ribo-hexopyranosyl)-4′-O-β-D-
glucopyranoside (Figure 1). This structure has not been
described previously, and we propose to name it serjanone A.
Reactive oxygen species are involved in the pathogenesis of
gastric lesions,43,44 and antioxidants play an important role in
protecting against such damage. It has been shown that rutin at
a dose of 200 mg kg−1 showed a gastroprotective effect against
50% ethanol-induced ulcers, and this effect may be related to
the antioxidant properties, since rutin was able to decrease the
levels of lipoperoxide and increase the antioxidant activity of
the enzyme GSH-Px.45 In addition, it was determined that the
production of free radicals increased after ulceration induced by
pylorus ligation in rats.46
Based on the information outlined above, a DPPH
antioxidant activity assay was performed on the 70% ethanolic
extract (EE), fractions (A−C), and selected pure compounds
(Table 4). The extract (EE) showed an IC50 of 69.6 μg mL
−1.
The activity was higher for fraction C (IC50 42.83 μg mL
−1).
The compounds isolated from this fraction were proanthocya-
nidin A-1, proanthocyanidin A-2, and cinnamtannin B-1. The
antioxidant activity of these compounds, as evaluated by the
DPPH assay, has been described previously. Cinnamtannin B-
1,29 isolated from the leaves of Ixora coccinea, showed an IC50 of
5.30 μg mL−1, and proanthocyanidins A-1 and A-2, isolated
from peanut skin, showed IC50 values of 8.55 and 9.71 μg mL
−1,
respectively.47 In general, compounds that are capable of
scavenging 50% of the DPPH radical at a concentration less
than or close to 10 μg mL−1 have a strong antioxidant activity.48
On the other hand, the major flavonoids cassiaoccidentalin A
(2) and tetrastigma B (3) did not show significant free radical
scavenging properties at the concentrations evaluated (0.625 to
20 μg mL−1). Therefore, we concluded that proanthocyanidins
are mostly responsible for the antioxidant activity of S.
marginata, which has strong free radical scavenging properties,
and probably also for the gastroprotective effect of the extract.
The correlation between tannins and gastroprotective effect was
described for Syzygium cumini,49 Eugenia dysenterica,50 and
Mouriri pusa.51
■ EXPERIMENTAL SECTION
General Experimental Procedures. Optical rotations were
determined using a PerkinElmer 241 polarimeter (589 nm, 20 °C).
Figure 4. Selected correlation observed in the HMBC spectrum (solid arrows) and ROE correlations (dashed arrows) for compound 4. Observed
coupling constants vs theoretical values for the O,C-fused glycopyranoside obtained using GMMX.42 MS/MS fragments shown from m/z 561 (ESI
positive mode) and 605 (ESI negative mode).
Table 3. 1H NMR (600 MHz) and 13C NMR (125 MHz)
Spectroscopic Data for Serjanone A (4) in MeOH-d4
position δC, type δH (J in Hz) HMBC
2 165.2, C










2′/6′ 129.1, CH 7.93, d (9.0) C-2, C-4′
3′/5′ 118.2, CH 7.27, d (9.0) C-1′, C-4′
4′ 162.1, C
α-2,6-dideoxy-5-hydroxy-ribo-hexopyranoside
1″ 64.5, CH 5.39, dd (5.0, 1.5) C-7, C-8, C-9,
C-3″, C-5″
2″ 37.4, CH2 2.48 (ddd, 14.7, 5.0, 3.6);
2.30 (ddd, 14.7, 1.5, 2.2)
3″ 67.0, CH 4.14 m
4″ 73.6, CH 3.66, d (4.5) C-6″
5″ 102.4, C
6″ 25.7, CH3 1.63, s C-7, C-4″, C-
5″
β-D-glucose
1‴ 101.7, CH 5.04, d (7.4)
2‴ 74.8, CH 3.49a C-3‴
3‴ 77.9, CH 3.49a C-2‴, C-4‴
4‴ 71.2, CH 3.40a C-3‴, C-5‴
5‴ 78.3, CH 3.49a C-3‴, C-4‴
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UV spectra were recorded on a Jasco V-630 spectrophotometer. 1D
and 2D NMR spectra were recorded on an Agilent 600 DD2
spectrometer and an Agilent 500 DD2 spectrometer equipped with a 5
mm 1H{15N−31P} PFG high-field inverse detection z-gradient probe.
1H (599.772 MHz) and 13C (125.666 MHz) NMR spectra were
recorded in pyridine-d5 and methanol-d4 at 25 °C. Chemical shifts are
given on the δ scale and are referenced to residual pyridine (δH 8.70,
7.55, 7.18 and δC 149.84, 135.50, 123.48) or methanol (δH 3.30 and δC
49.00). The Varian pulse sequence with a gradient was applied, and all
2D spectra, except for HMBC spectra of compound 4, were recorded
in the phase-sensitive mode. Exact masses were measured on a UPLC-
QTOF ESI (Waters Synapt G2, Manchester, UK) HRESI-TOFMS
instrument. Mass spectra were recorded in negative or positive ion
mode in the range m/z 100−2000 with a mass resolution of 20 000
and an acceleration voltage of 0.7 kV. The solvents used for the
preparation of extracts and chromatographic fractionation were
purchased from Prolabo VWR. Silica 60 F254 TLC plates (Merck)
were used to monitor the isolation process. Preparative silica gel TLC
(Merck, 0.25 mm) was used to purify some of the flavonoid fractions.
Compounds were visualized under UV254/366 light and by spraying
with H2SO4/H2O/HOAc (4:16:80 v/v/v). Sephadex LH-20 (Sigma-
Aldrich) and Kieselger 60 silica gel (200−60 μm, Merck) were used
for column chromatography. HPLC separations were carried out on a
Merck Hitachi system equipped with a LaChrom (L-2490) refractive
index detector and an analytical Phenomenex Gemini C18 column (4.6
× 250 mm, i.d) in isocratic mode.
Plant Material. Leaves of Serjania marginata Casar. were collected
in February 2011 in an area of Cerrado located at a latitude of
21°59′41.8″ S, a longitude of 55°19′24.9″ W, and an altitude of 429 m
in Dourados, Mato Grosso do Sul, Brazil. The plant was identified by
Arnildo Pott, and a voucher specimen (no. 41054) has been deposited
at the Herbarium of the Federal University of the Mato Grosso do Sul,
Brazil.
Extraction and Isolation. The dried leaves (500 g) were extracted
successively by percolation at room temperature with EtOH/H2O
(7:3, v/v). The ethanolic extract was filtered, concentrated under
vacuum at approximately 40 °C, and lyophilized to yield 163 g (33%)
of the powdered extract. The crude extract (5 g) was suspended in
H2O/n-BuOH (3:7, v/v) and then extracted with n-BuOH. The
solvent was removed to give 3.7 g (74%) of n-BuOH extract. A sample
of the n-BuOH extract (1.2 g) was purified on a Sephadex LH-20
column (4 × 300 mg) with MeOH as eluent to give three principal
fractions: A (0.420 g, 35%), B (0.299 g, 25%), and C (0.222 g, 18%).
Fraction A was chromatographed on silica gel CHCl3/MeOH (80:20
and 75:25) to give 3-O-D-β-glucopyranosylsitosterol (7 mg) and three
further fractions, which were purified by HPLC on an analytical C18
column (1 mL/min) with acetone/H2O (6:4) as the mobile phase to
give oleanolic acid 3-O-α-L-rhamnopyranosyl(1→2)[β-D-
glucopyranosyl(1→4)]-α-L-arabinopyranoside (2 mg), pulsatilla sap-
onin D (5 mg), compound 1 (20 mg), and salzmannianoside B (2
mg). Fraction B was chromatographed on silica gel CHCl3/MeOH/
H2O (65:30:5) to give quercetin 3-O-α-L-rhamnopyranoside (6 mg),
epicatechin (10 mg), and two further fractions, the first of which was
purified by preparative Si gel TLC CHCl3/MeOH/H2O (65:30:5) to
afford apigenin 6-C-β-boivinopyranosyl-7-O-β-D-glucopyranoside (2
mg), apigenin 6-C-[2-O-α-L-rhamnopyranosyl(1→2)]-β-D-xylopyrano-
side (1 mg), and compound 4 (0.7 mg). The second fraction was
purified by HPLC on an analytical column (1 mL/min) with MeOH/
H2O (45:55) as the mobile phase to afford cassiaoccidentalin A (2)
(10 mg) and tetrastigma B (3) (4 mg). Fraction C was purified by
HPLC on a semipreparative C18 column (2 mL/min) with MeOH/
H2O (4:6) acidified with 0.1% HOAc as the mobile phase to afford
proanthocyanidins A-1 (8 mg) and A-2 (9 mg) and cinnamtannin B-1
(17 mg).
Acid Hydrolysis of Fraction A. Fraction A (30 mg) was heated
under reflux in 1 N HCl (5 mL) for 3 h. The solution was extracted
with EtOAc. The aqueous layer, which contained the sugars, was
neutralized with Amberlite IR-45 (OH− form). The sample (19 mg)
was purified by preparative Si gel TLC (CH2Cl2/MeOH/H2O,
50:25:5) to afford rhamnose [0.9 mg, Rf = 0.39, [α]
20
D +6 (c 0.09,
H2O)]; arabinose [2 mg, Rf = 0.30, [α]
20
D +8 (c 0.2, H2O)]; and
glucose [1.7 mg, Rf = 0.23, [α]
20
D +22 (c 0.17, H2O)], which were
identified by comparison with authentic samples.
Acid Hydrolysis of Fraction B. Fraction B (23 mg) was heated
under reflux in 1 N HCl (2 mL) for 1 h. The mixture was allowed to
cool and was centrifuged. The supernatant, which contained the
sugars, was neutralized with Amberlite IR-45 (OH− form) and
concentrated. The sample (11 mg) was purified by preparative Si gel
TLC (CHCl3/MeOH/H2O, 65:30:5) to afford rhamnose [4 mg, Rf =
0.35, [α]20D +27 (c 0.15, H2O)] and glucose [0.9 mg, Rf = 0.15, [α]
20
D
+17 (c 0.09, H2O)], which were identified by comparison with
authentic samples.
Serjanioside D (1): amorphous, white powder; [α]20D +1 (c 0.2,
MeOH); 1H NMR (pyridine-d5, 600 MHz) and
13C NMR (pyridine-
d5, 125 MHz), see Table 1; HRESIMS m/z 1027.5475 [M − H]−
(calcd for C52H84O20, 1027.5478).
Serjanone A (4): amorphous, yellow powder; [α]20D +17 (c 0.1,
MeOH); UV λmax (log ε) 275 (3.77), 320 (sh) (3.67) nm;
1H NMR
(MeOH-d4, 600 MHz) and
13C NMR (MeOH-d4, 125 MHz), see
Table 3; HRESIMS m/z 561.1610 [M + 1]+ (calcd for C27H29O13,
561.1608); MS-MS ESI-pos (561(M + H)) 399 (M − glc + H); 381
(M − glc − H2O + H); 325 (M − glc − C3H6O2 + H); 297 (M − glc
− C4H6O3 + H); ESI-neg (605 (M + HCOOH − H)) 559 (M − H);
485 (M − C3H6O2 − H); 457 (M − C4H6O3 − H); 397 (M − glc −
H); 323 (M − glc − C3H6O2 − H); 295 (M − glc − C4H6O3 − H).
DPPH Photometric Assay. The antioxidant activities of 70%
ethanol extracts of the fractions and compounds 2 and 3 were
evaluated. Concentrations of 6.25, 12.5, 50, 100, and 200 μg mL−1
were tested for EE and fractions, in 96-well plates, in order to identify
the concentration for 50% inhibition (IC50) for each sample. Thus,
concentrations in the range 20 to 90 μg mL−1 for EE, 100 to 700 μg
mL−1 for fraction A, 100 to 400 μg mL−1 for fraction B, and 10 to 70
μg mL−1 for fraction C were tested to obtain the IC50. Pure
compounds were tested at 0.625 to 20 μg mL−1. The samples were
dissolved in MeOH/H2O (8:2), and 0.2 mL of a 0.004% DPPH
solution in MeOH/H2O (8:2) was added to 0.02 mL of the sample
solutions at different concentrations. The mixtures were allowed to
react at room temperature. After 30 min the absorbance values were
measured at 517 nm using a UV−vis spectrophotometer (BioTek
model Epoch). The blank consisted of 0.2 mL of DPPH and 0.02 mL
of MeOH/H2O (8:2). Standard solutions of gallic acid were prepared
and analyzed under identical conditions. The results are expressed
according to the percentage of inhibition, and this was calculated using
the following equation: Δ0% = 100 × (A0 − A)/A0, where Δ0% is the
percentage of sequestration, A0 is the absorbance of the blank, and A is
the absorbance of the sample after a reaction time of 30 min. The IC50
value was calculated by regression analysis in which concentrations
Table 4. Free Radical Scavenging Properties Obtained with
the DPPH Method of the Crude Extract, Fractions, and







cassiaoccidentalin A (2) −a





a(−) did not show free radical scavenging properties at concentrations
≤ 20 μg mL−1. bValue reported by Zhang and co-workers.47 cValue
reported by Idowu and co-workers.29
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tested versus percentage of sequestration are used. All tests were
carried out in triplicate.
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sejeriá de Economiá Innovacioń y Ciencia, Junta de Andaluciá
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baseado em APG III; Instituto Plantarum: Nova Odessa, 2013; pp
454−459.
(2) Sparg, S. G.; Light, M. E.; Van Staden, J. J. Ethnopharmacol. 2004,
94, 219−243.
(3) Lima, M. R. F.; Luna, J. S.; Santos, A. F.; Andrade, M. C. C.;
Sant’Ana, A. E. G.; Genet, J. P.; Marquez, B.; Neuville, L.; Moreau, N.
J. Ethnopharmacol. 2006, 105, 137−147.
(4) Cardoso, C. A. L.; Coelho, R. G.; Honda, N. K.; Pott, A.; Pavan,
F. R.; Leite, C. Q. F. Braz. J. Pharm. Sci. 2013, 49, 775−782.
(5) Moreira, R. P. M.; Batista, C. S.; Guarim Neto, G. Flovet 2013, 5,
1−21.
(6) Gomig, F.; Pietrovski, E. F.; Guedes, A.; Dalmarco, E. M.;
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Osorio-Rodríguez, L.; Moo-Puc, R. E.; Peña-Rodríguez, L. M.
Parasitol. Res. 2012, 110, 31−35.
(14) Silva, J. L. V.; Carvalho, V. S.; Silva, F. L.; Barbosa-Filho, J. M.;
Rigoni, V. L. S.; Nouailhetas, V. L. A. Pharmacologyonline 2012, 1, 22−
26.
(15) Teixeira, J. R. M.; Lapa, A. J.; Souccar, C.; Valle, J. R. J.
Ethnopharmacol. 1984, 10, 311−318.
(16) Chav́ez, M. I.; Delgado, G. Tetrahedron 1994, 50, 3869−3878.
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Ulcerosa Peṕtica Experimental. MSc. Dissertaca̧ ̃o; UNESP: Araraquara,
SP, 2014.
(18) Joly, C. A.; Haddad, C. F. B.; Verdade, L. M.; Oliveira, M. C.;
Bolzani, V. S.; Berlink, R. G. S. Rev. USP 2011, 89, 114−133.
(19) Montruchio, D. P.; Miguel, O. G.; Miguel, M. D.; Monache, F.
D.; Carvalho, J. L. S. Visa ̃o Acad. 2005, 6, 48−52.
(20) Kang, S. S. Arch. Pharma Res. 1989, 12, 42−27.
(21) Schenkel, P.; Werner, W.; Schulte, K. E. Planta Med. 1991, 57,
463−467.
(22) Santos, P. M. L.; Schripsema, J.; Kuster, R. M. Rev. Bras.
Farmacogn. 2005, 15, 321−325.
(23) Lôbo, L. T.; Castro, K. C. F.; Arruda, M. S. P.; Silva, M. N.;
Arruda, A. C.; Müller, A. H.; Arruda, G. N. S.; Santos, A. S.; Filho, A.
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